(2023) showed that ATF4 expression was significantly increased in the hearts of mice with diabetic cardiomyopathy, and deletion of ATF4 improved cardiac dysfunction through inhibiting oxidative stress, reducing cardiomyocyte apoptosis and alleviating cardiac fibrosis in diabetic mice. Here, ATF4 is linked to diabetic cardiomyopathy.